Clinical Trials Directory

Trials / Unknown

UnknownNCT04165902

Additional Effects of Steroid and Dextrose to Hyaluronic Acid on Knee Osteoarthritis

Additional Therapeutic Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis: a Double-blind, Randomized-controlled Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Taipei Medical University · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Using double-blind, randomized controlled design to compare the immediate, short-term and intermediate-term additional therapeutic effects of ultrasound-guided corticosteroid injection and dextrose injection of hyaluronic acid injection on patients with knee osteoarthritis, under the basis of International Classification of Functioning, Disability, and Health.

Detailed description

A total of 60 patients will be collected. The participants will be randomized into two groups, including hyaluronic acid combined corticosteroid group and hyaluronic acid combined dextrose group. The balance, physical activity (10 meters normal and fast walk, up and downstairs, and 5 repeated chair-rising time, timed up and go test), functional performance and knee-related quality of life (Western Ontario and McMaster Universities Osteoarthritis index、Knee Injury and Osteoarthritis Outcome Score) will be evaluated. All the evaluations will be re-evaluated at one week after injection, one month after injection, three months after injection, and six months after injection. Subjects and evaluators will be both blinded to the group's classification during the whole course of study.

Conditions

Interventions

TypeNameDescription
DRUGcompare the effects of steroid plus hyaluronic acid and destrose plus hyaluronic acid on knee osteroarthritiscompare the immediate effect (one week after 3 times of injections), short-term effects (one month and three months after 3 times of injections), and midterm effect (6 months after 3 times of injections).

Timeline

Start date
2019-11-11
Primary completion
2020-07-31
Completion
2020-07-31
First posted
2019-11-18
Last updated
2019-11-19

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04165902. Inclusion in this directory is not an endorsement.